Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy.

Sultanik, Philippe; Mallet, Vincent; Lagaye, Sylvie; Casrouge, Armanda; Dorival, Céline; Barthe, Yoann; Fontaine, Hélène; Hézode, Christophe; Mottez, Estelle; Bronowicki, Jean-Pierre; Carrat, Fabrice; Theodorou, Ioannis; Abel, Laurent; Gayat, Etienne; Fontanet, Arnaud; Pol, Stanislas; Albert, Matthew L.
Liver Int; 35(7): 1833-44, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25556540